Delivery Order SPE2DB25D3003-SPE2DB25FPWJH
- Not listed
- The Defense Logistics Agency awarded a $15,047.95 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price, non-set-aside contract that leverages AmerisourceBergen's existing pharmaceutical supply infrastructure. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,723.83 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The delivery will be...
- The Defense Logistics Agency awarded a delivery order valued at $16,372.29 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, awarded on August 4, 2025, represents a non-competitive set-aside contract and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,354.64 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for $8,526.60 to supply DESCOVY 200-25 mg tablets in quantities of 30 units. The contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, utilizes firm fixed pricing and is not designated as a set-aside contract. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,762.29 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 29, 2025, with completion targeted for September 2, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,303.18 on August 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $27,419.98 and an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This contract, valued at $6,546.24, represents a firm fixed price delivery order with an ultimate completion date of June 17, 2025. The award was made on a competitive, non-set-aside basis and is performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWJHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $32,034.58 on May 12, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to the Department of Defense and other federal healthcare systems. As a prime contractor on the DLA's pharmaceutical supply contracts, the company supplies a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. DESCOVY, an antiretroviral medication used in HIV treatment and prevention, reflects AmerisourceBergen's role in supporting the military health system's comprehensive pharmaceutical needs. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet stringent federal procurement requirements and its significance as a key vendor within the Defense Health Agency supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.0k | 5/12/25 |